Bridgewater Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Bridgewater Advisors's REGN Position: Q3 2026 in Review
Bridgewater Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q3 2026, buying an estimated $9.07K and bringing the position to 352 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #365.
Bridgewater Advisors first reported a position in REGN in Q4 2025 and has held it in 4 quarters since. 1,433 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Bridgewater Advisors held 352 shares of Regeneron Pharmaceuticals worth $312K as of Q3 2026.
- Bridgewater Advisors bought 12 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $9.07K.
- Regeneron Pharmaceuticals made up 0.02% of Bridgewater Advisors's portfolio in Q3 2026, its #365 holding.
- Bridgewater Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 1,433 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Bridgewater Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.